Anzeige
Erschienen in:
29.08.2023 | Epidemiology
Diagnostic performance of screening mammography according to menstrual cycle among Asian women
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2023
Einloggen, um Zugang zu erhaltenAbstract
Purpose
To investigate the performance metrics of screening mammography according to menstrual cycle week in premenopausal Asian women.
Methods
This retrospective study included 69,556 premenopausal Asian women who underwent their first screening mammography between 2011 and 2019. The presence or absence of a breast cancer diagnosis within 12 months after the index screening mammography served as the reference standard, determined by linking the study data to the national cancer registry data. Menstrual cycles were calculated, and participants were assigned to groups according to weeks 1–4. The performance metrics included cancer detection rate (CDR), sensitivity, specificity, and positive predictive value (PPV), with comparisons across menstrual cycles.
Results
Among menstrual cycles, the lowest CDR at 4.7 per 1000 women (95% confidence interval [CI], 3.8–5.8 per 1000 women) was observed in week 4 (all P < 0.05). The highest sensitivity of 72.7% (95% CI, 61.4–82.3) was observed in week 1, although the results failed to reach statistical significance. The highest specificity of 80.4% (95% CI, 79.5–81.3%) was observed in week 1 (P = 0.01). The lowest PPV of 2.2% (95% CI, 1.8–2.7) was observed in week 4 (all P < 0.05).
Conclusion
Screening mammography tended to show a higher performance during week 1 and a lower performance during week 4 of the menstrual cycle among Asian women. These results emphasize the importance of timing recommendations that consider menstrual cycles to optimize the effectiveness of screening mammography for breast cancer detection.